Literature DB >> 19205880

S100beta protein expression: gender- and age-related daily changes.

M I Nogueira1, S Y Abbas, L G M Campos, W Allemandi, P Lawson, S H Takada, E C Azmitia.   

Abstract

S100beta is a soluble protein released by glial cells mainly under the activation of the 5-HT1A receptor. It has been reported as a neuro-trophic and -tropic factor that promotes neurite maturation and outgrowth during development. This protein also plays a role in axonal stability and the plasticity underlying long-term potentiation in adult brains. The ability of S100beta to rapidly regulate neuronal morphology raises the interesting point of whether there are daily rhythm or gender differences in S100beta level in the brain. To answer this question, the S100beta expression in adult female and male rats, as well as in adult female CD-21 and S100beta -/- female mice, were investigated. Scintillation counting and morphometric analysis of the immunoreactivity of S100beta, showed rhythmic daily expression. The female and male rats showed opposite cycles. Females presented the highest value at the beginning of the rest phase (5:00 h), while in males the maximum value appeared in the beginning of the motor activity period (21:00 h). These results confirm previous S100beta evaluations in human serum and cerebrospinal fluid reporting the protein's function as a biomarker for brain damage (Gazzolo et al. in Clin Chem 49:967-970, 2003; Clin Chim Acta 330:131-133, 2003; Pediatr Res 58:1170-1174, 2005), similar behavior was also observed for GFAP in relation to Alzheimer Disease (Fukuyama et al. in Eur Neurol 46:35-38, 2001). The data should be taken into account when considering S100beta as a biomarker of health condition. In addition, the results raise questions on which structure or condition imposes these rhythms as well as on the physiological meaning of the observed gender differences.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19205880     DOI: 10.1007/s11064-009-9915-x

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  45 in total

1.  Intralesional injection of interferon gamma affects reactive proliferation of astrocytes in the neonatal rat brain. A preliminary study of the age-dependent effect.

Authors:  R Pawliński; Z Setkowicz; M Ziaja; Z Sołtys; K Janeczko
Journal:  Folia Histochem Cytobiol       Date:  1999       Impact factor: 1.698

2.  S100B protein in urine of preterm newborns with ominous outcome.

Authors:  Diego Gazzolo; Pasquale Florio; Sabina Ciotti; Emanuela Marinoni; Romolo di Iorio; Matteo Bruschettini; Renata Sacchi; Giovanni Serra; Mario Lituania; Fabrizio Michetti
Journal:  Pediatr Res       Date:  2005-12       Impact factor: 3.756

3.  Calcium and fos involvement in brain-derived Ca(2+)-binding protein (S100)-dependent apoptosis in rat phaeochromocytoma cells.

Authors:  S Fulle; T Pietrangelo; M A Mariggiò; P Lorenzon; L Racanicchi; J Mozrzymas; S Guarnieri; G Zucconi-Grassi; G Fanò
Journal:  Exp Physiol       Date:  2000-05       Impact factor: 2.969

4.  The effects of age and experience on memory for visually presented music.

Authors:  E J Meinz; T A Salthouse
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  1998-01       Impact factor: 4.077

5.  Increased S100beta in the cerebrospinal fluid of patients with frontotemporal dementia.

Authors:  A J Green; R J Harvey; E J Thompson; M N Rossor
Journal:  Neurosci Lett       Date:  1997-10-10       Impact factor: 3.046

6.  Enhanced synaptophysin immunoreactivity in rat hippocampal culture by 5-HT 1A agonist, S100b, and corticosteroid receptor agonists.

Authors:  M Nishi; P M Whitaker-Azmitia; E C Azmitia
Journal:  Synapse       Date:  1996-05       Impact factor: 2.562

Review 7.  Chemistry and biology of the S-100 protein.

Authors:  B W Moore
Journal:  Scand J Immunol Suppl       Date:  1982

8.  Prednisone induces anxiety and glial cerebral changes in rats.

Authors:  O Gonzalez-Perez; C Ramos-Remus; J Garcia-Estrada; S Luquin
Journal:  J Rheumatol       Date:  2001-11       Impact factor: 4.666

9.  Increased serum S100B protein in schizophrenia: a study in medication-free patients.

Authors:  D R Lara; C S Gama; P Belmonte-de-Abreu; L V Portela; C A Gonçalves; M Fonseca; S Hauck; D O Souza
Journal:  J Psychiatr Res       Date:  2001 Jan-Feb       Impact factor: 4.791

10.  S100B is increased in mood disorders and may be reduced by antidepressive treatment.

Authors:  Matthias L Schroeter; Hashim Abdul-Khaliq; Albert Diefenbacher; Ingolf E Blasig
Journal:  Neuroreport       Date:  2002-09-16       Impact factor: 1.837

View more
  4 in total

1.  Treadmill training restores spatial cognitive deficits and neurochemical alterations in the hippocampus of rats submitted to an intracerebroventricular administration of streptozotocin.

Authors:  Letícia Rodrigues; Márcio Ferreira Dutra; Jocemar Ilha; Regina Biasibetti; André Quincozes-Santos; Marina C Leite; Simone Marcuzzo; Matilde Achaval; Carlos-Alberto Gonçalves
Journal:  J Neural Transm (Vienna)       Date:  2010-10-16       Impact factor: 3.575

2.  PSAPP mice exhibit regionally selective reductions in gliosis and plaque deposition in response to S100B ablation.

Authors:  Emily Roltsch; Leigh Holcomb; Keith A Young; Alexander Marks; Danna B Zimmer
Journal:  J Neuroinflammation       Date:  2010-11-16       Impact factor: 8.322

3.  Targeting S100B Protein as a Surrogate Biomarker and its Role in Various Neurological Disorders.

Authors:  Urvashi Langeh; Shamsher Singh
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

Review 4.  S100 Proteins in Fatty Liver Disease and Hepatocellular Carcinoma.

Authors:  Etienne Delangre; Ezia Oppliger; Serkan Berkcan; Monika Gjorgjieva; Marta Correia de Sousa; Michelangelo Foti
Journal:  Int J Mol Sci       Date:  2022-09-20       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.